课题基金 / 基金详情

Role of the p53 homolog p73 in cancer

Role of the p53 homolog p73 in cancer
p53 同源物 p73 在癌症中的作用
批准号:
7487702
负责人:
UTE Martha MOLL
金额:
$7.75万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-14 至 2008-07-31

项目摘要

项目成果

UTE Martha MOLL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Principal Investigator/Program Director (Last, first, middle): Moll, Ute, M Title: the Role of p63 and p73 in Cancer PI: Ute M. Moll, M.D. Abstract p53 controls a powerful stress response and is a quintessential tumor suppressor. The discovery of p63 and p73, two p53 family members, provoked much speculation about their individual and collective functions. However, while a strong consensus exists that both genes play a major role in cancer, current data is conflicting whether their nature is tumor suppressive, oncogenic or in some context both. Although their function in development was immediately apparent from gene ablation studies, delineating their exact role in cancer remains elusive due to a lack of clear genetic data in humans and mice. Due to a second internal promoter and alternative splicing, p63 and p73 are complex bipolar genes giving rise to multiple isoforms that can simplistically be viewed as Two Opposing-Genes-in-One. Moreover, in sharp contrast to the ubiquitous mutational alteration of p53, p63 and p73 are characterized by a virtual absence of inactivating mutations, and instead exhibit aberrant expression of specific isoforms in tumors. This grant aims at elucidating the in vivo role of both genes in specific oncogenic contexts and is based on two premises. First, normal tissues exhibit a striking specificity for tissue types and isoforms in their p63 and p73 expression, an important fact that up to now received little attention, yet likely holds the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
Targeting stabilized mutant p53 protein
海外基金